Reagent anti-d bioclone 150ML monoclonal
Ended Awarded Last action
- Contract number
- SPE2D325F390N
- Awardee
-
Quidelortho Sales Company, LLC UEI ZFXRG96JMJ39
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,037
Award facts
- Contract value 100% obligated
- $1,037.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Raritan, NJ 08869, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Medical Supply Chain issued a delivery order to Quidelortho Sales Company, LLC for $1,037.23 on September 5, 2025, for Reagent Anti-D Bioclone 150ML Monoclonal, with ultimate completion on September 10, 2025.
Place of performance is Raritan, New Jersey. The order carries firm fixed price terms and no set-aside. Quidelortho is a HUBZone-certified joint venture supplying medical diagnostic equipment, laboratory analyzers, reagents, and clinical testing consumables to federal healthcare agencies.
Quick answers
Who was awarded contract SPE2D325F390N?
SPE2D325F390N was awarded to Quidelortho Sales Company, LLC by Medical Supply Chain (Troop Support) on September 5, 2025.
How much is contract SPE2D325F390N worth?
The government has obligated $1,037 on SPE2D325F390N.
Is contract SPE2D325F390N an order under another contract?
Yes. SPE2D325F390N is a delivery order under SPE2D018D0005, an indefinite delivery contract.
Was contract SPE2D325F390N competed?
The extent of competition for SPE2D325F390N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award